Generix Group : 1st Half 2016/2017 Results: Ebitda of 6%

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Generix Group : 1st Half 2016/2017 Results: Ebitda of 6% of revenue

1st Half 2016/2017 Results Ebitda of 6% of revenue

Paris, November 28, 2016 - Generix Group, Industrial, Logistical and Retail Ecosystems provider with leading Collaborative Software Solutions, today issued its interim financial statements for the six-month period ended September 30, 2016.

SaaS revenue growth of 32%

The strategic change of direction over the last few years has enabled SaaS, the primary activity in terms of generating growth, to show an increase of 32% over the first half of the 2016/2017 year.

Generix Group thus confirms its position as an application service provider with nearly 50% of its revenue generated by its SaaS model (including the associated Conseil & Services activities). 

The loyalty of the established base also enabled Generix Group to show a growth of 25% in license sales.

  Six months ended September 30, Variation
IFRS consolidated accounts, in millions of Euros 2016 2015 M€ %
Revenues 29,6 27,3 2,3 9%
Which licenses 2,1 1,7 0,4 25%
Which maintenance 8,7 8,8 -0,1 -1%
Which SaaS 10,6 8,0 2,6 32%
Which Consulting Services 8,2 8,8 -0,6 -7%
Operational expenses / other income -28,5 -25,7 -2,8 11%
Profit (loss) from current operations 1,1 1,5 -0,4 -29%
Other operational income and expenses -0,4 -0,3 -0,1 43%
Profit (loss) from operations 0,6 1,2 -0,6 -47%
Financial expenses -0,1 -0,1 0,0 36%
Loss before income taxes 0,5 1,1 -0,6 -54%
Income taxes benefit -0,2 -0,4 0,2 -56%
Net result after tax 0,3 0,7 -0,4 -53%
Net result 0,3 0,7 -0,4 -54%
  Six months ended September 30, Variation
EBITDA  in millions of euros 2016 2015 proforma 2015 published M€ %
Revenues   29,6  27,3 27,3 2,3 9%
Other income from operations   0,6  0,6 0,6 0,0 2%
Cost of goods sold -  0,4  -0,5 -0,5 0,1 -11%
Other purchases and external expenses -  9,7  -8,8 -8,8 -0,9 11%
Taxes and similar payments -  0,7  -0,6 -0,6 0,0 6%
Personnel costs -  16,5  -15,3 -15,3 -1,3 8%
Other expenses on operations -  0,3  -0,2 -0,2 -0,1 36%
Reversals of used provisions during the period -  0,0  0,0 0,0 0,0 N/A
Capitalized production -  0,8  -0,5 -0,5 -0,4 74%
Sales commissions spread (2)   -  0,0 -0,6 0,0 N/A
EBITDA (1)   1,8  2,1 1,5 -0,3 -14%
  1. EBITDA = current operating income + net provisions on current assets + net provisions for risks and charges + depreciation on fixed assets - capitalized production costs.  
  2. In order to interpret this economic performance in a pertinent way, the staggering of sales bonuses has been included in the EBITDA figure since March 31, 2016.

Over the half year, the Group showed an Ebitda of 6% of its revenue (or €1.8 million). The drop in Ebitda compared to revenue is primarily due to the reinforcement of our sales force.

The net impact of activated software expenses, net depreciation charges and provisions amounts to -€0.7 million, bringing the recurring operating income to €1.1 million. 

After figuring in the other operating expenses, which primarily correspond with the costs of acquisitions, the operating income amounts to €0.6 million.

International development cash flow

  

  Six months ended September 30, Variation
Net debt, in millions of Euros 2016 2015 M€ %
Cash and cash equivalents, end of period 1,6 -1,5 3,1 -206%
Short-term and long-term portions of financial obligations -12,5 -5,8 -6,7 115%
Net debt -10,9 -7,3 -3,6 49%
  Six months ended September 30, Variation
Consolidated statements of cash flows, in millions of Euros 2016 2015 M€ %
Net income adjusted by non-cash items 1,7 1,8 0,0 -2%
Change in working capital -8,1 -7,9 -0,3 3%
Net cash by operating activities -6,4 -6,1 -0,3 5%
Net cash used in investing activities -2,1 -2,1 0,0 2%
Free cash flow -8,5 -8,2 -0,4 4%
Net cash by financing activities 4,6 -1,4 6,0 -439%
Net increase in cash and cash equivalent -3,9 -9,5 5,6 -59%
Cash and cash equivalent, end of period 1,6 -1,5 3,1 -204%

The cash flow statement expresses the flows between March 31 and September 30, 2016 in comparison to the same period last fiscal year. Between these two dates, the working capital requirements increased due to paying for annual maintenance contracts invoiced at the start of the calendar year and accounted for in revenues over the entire year.

The cash flow of the last half of the year was marked by an increase of €6 million in net treasury corresponding with financing activities, and in particular the taking out of a middle-term loan of €4.5 million as part of the takeover of the Sologlobe Logistiques Inc. company, which was finalized on October 3, 2016. This figure may be compared with the reimbursement of €1.4 million over the same half-year period of the previous financial year.

Prospects

Generix Group confidently faces the second half of the year. The acquisition of the Canadienne Sologlobe Logistiques Inc. company enable the Group to develop internationally since it represents a direct approach to the North American continent, representing nearly half of the world's market in supply chain software investments.

Supplemental and non-IFRS Financial Information

Supplemental non-IFRS information (above-mentioned as Ebitda or net debt) presented in this press release are subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Company's supplemental non-IFRS financial information may not be comparable to similarly titled non-IFRS measures used by other companies.

***

The Half-Year Financial Report at September 30, 2016 is available for download at the address: http://www.generixgroup.com/fr/liste/rapports-financiers/

Next press release: January 30, 2017 after closing of the stock exchange Revenues for the third quarter of financial year 2016/2017

Contacts

Ludovic Luzza Chief Financial Officer Tel: +33 (0)1 77 45 42 80 lluzza@generixgroup.com www.generixgroup.com   Stéphanie Stahr CM-CIC Market Solutions Tel: +33 (0)1 53 48 80 57 stephanie.stahr@cmcic.fr www.cmcics.com

About Generix Group

Software editor of collaborative applications, Generix Group helps its customers to face digital enterprise challenges: facilitating buying journeys, building a digital supply chain, and dematerializing all data flows. By building differentiating services, Generix Group optimizes the overall performance of the company within its ecosystem, enabling it to meet customers' new expectations.

Over 5,000 international players have contributed to establishing Generix Group as a European leader, with close to €58 million in turnover

For more information, visit www.generixgroup.com

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...4229b4b389

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 0

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 0

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 2

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 0

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 0

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 0

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading

Top 5 Most Recently Viewed Articles

Securiti Earns Noteworthy AWS Security Competency in AI

Updated Category News Views 375

Securiti Achieves AWS Security Competency Status in AI Security Securiti, the pioneer of the Data+AI Command Center, proudly announces its recent achievement of Amazon Web Services (AWS) Security Competency status in the innovative AI Security category. This new milestone highlights Securiti as one of the select inaugural partners recognized by AWS for its exceptional...

Continue Reading
Exciting Family Medicine Forum in Winnipeg This Fall

Updated Category News Views 204

Join the Family Medicine Forum in Winnipeg Mark your calendars, as the Family Medicine Forum is heading to Winnipeg this November for an enriching experience that promises to bring together family physicians from across the nation. This premier event is not only a chance to learn but to celebrate the vital work family doctors do every day. The Essence of Family Medicine...

Continue Reading
Man Group PLC Reveals Interest in Dowlais Group Securities

Updated Category News Views 106

Understanding the Disclosure by Man Group PLC In the realm of financial markets, disclosures play a crucial role in maintaining transparency and informing stakeholders about significant market movements. Recently, Man Group PLC made headlines by revealing its position regarding Dowlais Group PLC's relevant securities. This disclosure is essential as it reflects the...

Continue Reading
Experity Welcomes Bobby Ghoshal as New COO and President

Updated Category News Views 371

Experity Welcomes Bobby Ghoshal as President and COO Experity, a leader in on-demand healthcare solutions, has appointed Bobby Ghoshal as its new President and Chief Operating Officer. In this important role, Mr. Ghoshal will spearhead daily operations, steering the strategic direction for the company. His appointment is pivotal in enhancing Experity's mission to serve...

Continue Reading
LifeMD's Upcoming Engagements at Major Investor Conferences

Updated Category News Views 96

LifeMD's Upcoming Engagements at Major Investor Conferences LifeMD, Inc. (Nasdaq: LFMD), a trailblazer in virtual primary care, has recently announced its participation in several prominent investor conferences this September. As a company recognized for its innovative approach in telemedicine, LifeMD’s management is eager to showcase their vision and accomplishments to...

Continue Reading